BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  BioAlliance Pharma Sitavig® Licensing Strategy Execution Of Licensing Agreement With Innocutis For North America

  March 19, 2014

   · 

  7 min read
• BioForest

  Plandai Biotechnology, Inc. Completes Stage 1 Of Senteeko Phytofare Factory, Readies For Production

  March 19, 2014

   · 

  3 min read
• Biotech Bay

  Singulex, Inc.’s Proprietary Ultrasensitive Research Test For Cardiac Troponin-I Predicts Coronary Heart Disease In The General Population

  March 19, 2014

   · 

  1 min read
• Biotech Bay

  Vista Partners Initiates Coverage On Soligenix; $5.50 Price Target

  March 19, 2014

   · 

  2 min read
• Pharm Country

  Hemispherx Biopharma To Present Clinical Interpretations On CFS Treatment At The 11th Biennial International Research And Clinical Conference

  March 19, 2014

   · 

  1 min read
• Drug Development

  Novo Nordisk A/S Reports Positive Results From First Phase 3 Trial With N8-GP, A Long-Acting Factor VIII For Treatment Of Haemophilia A

  March 19, 2014

   · 

  1 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Initiates Phase 3 Study Of Andexanet Alfa, Potential First-In-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway

  March 19, 2014

   · 

  1 min read
• Drug Development

  Seventh Cohort Underway In Cellceutix Clinical Trial Of Kevetrin For Solid Tumors

  March 19, 2014

   · 

  4 min read
• Bio NC

  North Carolina Life Sciences Industry Featured On BioSpace Map

  March 19, 2014

   · 

  1 min read